Biotech News
Related news
RGENRepligen2026-08-26 11:30 EST
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
RGENRepligen2026-05-07 11:30 EST
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
WVEWave Life Sciences2026-11-11 13:30 EST
Wave Life Sciences to Present at Jefferies Global Healthcare Conference in London
WVEWave Life Sciences2026-10-13 12:30 EST
Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference
TECHBio-Techne2026-05-04 11:00 EST
Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
TECHBio-Techne2025-12-23 12:00 EST
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference
TXG10x Genomics2021-08-31 20:05 EST
10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
TXG10x Genomics2021-04-29 20:05 EST
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
AZTAAzenta Life Sciences2026-11-17 21:10 EST
Azenta to Participate in the 9th Annual Evercore Healthcare Conference
SLSSELLAS Life Sciences Group, Inc.2026-09-02 12:30 EST
SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer
Repligen
Bioprocessing Technology Supplier Repligen is a global life sciences company focused on technologies and systems used in biologic drug manufacturing. Its customers include biopharmaceutical developers and contract development and manufacturing organizations seeking greater efficiency, control, and scalability in production. Four Core...
Recent company news
RGENRepligen2026-11-04 12:00 EST
Repligen Corporation to Present at Jefferies Global Healthcare Conference
RGENRepligen2026-10-30 10:00 EST
Repligen Announces $1 Billion Private Convertible Senior Notes Transaction
RGENRepligen2026-10-27 11:00 EST
Repligen Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
RGENRepligen2026-10-06 13:05 EST
Repligen Completes Acquisition of BioLife Solutions
RGENRepligen2026-08-26 11:30 EST
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Stock data
- Close
- 170.29 USD
- Market cap
- 6.83B USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
